Events Partner Content Cell and Gene Therapy Manufacturing Forum Last year we told you that the cell and gene industry would be worth $9 - $14 billion by 2026. We were wrong.
Oncology On the forefront of healthcare change, turning innovative sc... Claus Zieler, chief commercial and medical affairs officer & member of the Executive Committee at Astellas Pharma, spoke with pharmaphorum at ASCO25.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face